Krystal Biotech KRYS
NASDAQ KRYS
$308.81 +2.31 (+0.75%)
At close: Nov 11, 2026 · 4:00 PM EST

Krystal Biotech (KRYS) Change in Accrued Expenses (2016 - 2026)

Updated

Krystal Biotech (KRYS) recorded Change in Accrued Expenses of $3.4 million in Q3 2026, down 42.5% from $5.92 million a year earlier and down 37.4% from the prior quarter.

Analysis

Krystal Biotech (KRYS) Change in Accrued Expenses (2016 - 2026) Analysis & Trends

On a TTM basis, Krystal Biotech's Change in Accrued Expenses came in at $8.31 million as of Sep 30, 2026, down 47.4% year-over-year; for FY2025, it was $14.1 million, up 161.6% from FY2024.

  • Annual Change in Accrued Expenses has a five-year compound annual growth rate of 43.7% (FY2020 to FY2025).
  • Across earlier years, Change in Accrued Expenses came in at $5.39 million in FY2024 (+18.3%), $4.56 million in FY2023 (-11.9%), $5.17 million in FY2022 (+91.2%) and $2.71 million in FY2021 (+17.4%).
  • Quarterly Change in Accrued Expenses has ranged from -$6.31 million in Q1 2026 to $7.48 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Change in Accrued Expenses rose in two of the last four quarters, with growth averaging 60.7%.
  • Peak year-over-year performance for Change in Accrued Expenses in the last five years was growth of 629.3% in Q1 2022, against a decline of 86.3% in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $5.44 million (Q2 2026), -$6.31 million (Q1 2026) and $5.79 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Krystal Biotech 9.08 Bn 5.67 Bn 119.79 Mn 3.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.40 Mn
Jun 30, 2026 5.44 Mn
Mar 31, 2026 -6.31 Mn
Dec 31, 2025 5.79 Mn
Sep 30, 2025 5.92 Mn
Jun 30, 2025 -1.29 Mn
Mar 31, 2025 3.70 Mn
Dec 31, 2024 7.48 Mn
Sep 30, 2024 1.94 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 -5.16 Mn
Dec 31, 2023 3.68 Mn
Sep 30, 2023 2.54 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 -3.46 Mn
Dec 31, 2022 2.16 Mn
Sep 30, 2022 540,000.00
Jun 30, 2022 463,000.00
Mar 31, 2022 2.01 Mn
Dec 31, 2021 -4.02 Mn
API Access

Krystal Biotech Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KRYS&period=max&api_key=YOUR_API_KEY